回复Gad等人的“罗氏催乳素II免疫测定新参考区间的临床影响”。

{"title":"回复Gad等人的“罗氏催乳素II免疫测定新参考区间的临床影响”。","authors":"Robert D. Nerenz, Bradley R. Javorsky, Jenna Sarvaideo, Joely A. Straseski, Erin Earll","doi":"10.1111/cen.15191","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"102 5","pages":"557-558"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In Reply to Gad Et Al “Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay”\",\"authors\":\"Robert D. Nerenz, Bradley R. Javorsky, Jenna Sarvaideo, Joely A. Straseski, Erin Earll\",\"doi\":\"10.1111/cen.15191\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10346,\"journal\":{\"name\":\"Clinical Endocrinology\",\"volume\":\"102 5\",\"pages\":\"557-558\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Endocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cen.15191\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cen.15191","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}